BX vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

BX

56.5
AI Score
VS
BX Wins

CNS

52.5
AI Score

Investment Advisor Scores

BX

57score
Recommendation
HOLD

CNS

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BX CNS Winner
Revenue 3.62B 94.41M BX
Net Income 649.73M 29.96M BX
Net Margin 18.0% 31.7% CNS
ROE 7.8% 9.9% CNS
ROA 1.3% 6.7% CNS
Total Assets 48.33B 450.12M BX
Cash 2.45B 193.73M BX
Free Cash Flow 957.64M 4.31M BX

Relative Price Performance (Last 90 Days)

BX 1M: +10.3% · 3M: +10.6% CNS 1M: +6.8% · 3M: +24.3%

Current Technical Phase

BX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.0% over 20 days), RSI 65

RSI (14): 65.0 · Price: $136.12

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.5% over 20 days), RSI 67

RSI (14): 66.5 · Price: $84.89

Fundamentals Snapshot

Metric BX CNS
Market Cap
Forward P/E 18.0 21.8
Trailing P/E 28.6 25.3
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.5% 0.3%
EPS 4.47 3.25
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, BX is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.